Introduction
Recently, growing attention is focused on the heath beneficial effects of fermented milk products. one of the mechanisms of the favourable influence of these products is the presence of biogenic compounds (9) . these compounds are natural metabolic products of growing microorganisms in the fermentation process or their cellular components accumulated in fermented milk products. typical representatives of these biogenic compounds are the bioactive peptides derived from the decomposition of milk proteins by digestive enzymes or fermentation with lactic acid bacteria. Such peptides can play a regulatory role in the human organism somewhat similar to hormones. therefore, some milk derived peptides have antithrombotic effect, influence the immune response or regulate blood pressure (3) .
the antihypertensive effect of fermented milks is attributed to the formation of peptides inhibiting the human angiotensinconverting enzyme (Ace), an enzyme deeply involved in blood pressure regulation. Such peptides are produced from casein by lactic acid bacteria during fermentation due to the activity of specific enzymes -proteases and peptidases. Therefore only selected strains of Lactobacillus helveticus and L. casei have been reported to produce fermented milk with Ace inhibitory activity (AceiA) (2, 4, 6, 10, 11) . takano (8) reports AceiA in fermented milk products with the above species, but also for strains of L. delbrueckii ssp. bulgaricus and ssp. lactis.
on the base of strain L. helveticus СР790, (4) the Japanese company calpis Food industry co. released on the market a fermented milk product calpis with in vivo proven antihypertensive effect. the product is obtained from non-fat milk co-fermented by L. helveticus СР790 and the yeast Saccharomyces cerevisiae. later Yamamoto et al. (11) demonstrated that antihypertensive functional food can be produced from milk fermented with single culture of L. helveticus СРN4. On the European market a fermented milk drink "evolus" with antihypertensive effect is offered by the Finnish company "Valio". the product is obtained with a culture of L. helveticus 16Н.
the aim of the present study was to evaluate the potential of previously selected L. helveticus and L. delbrueckii ssp. bulgaricus strains (7) to accumulate ACEIA in fermented milk, produced under different conditions.
Materials and Methods

Strains and fermentation conditions
Five strains exhibiting high AceiA were previously selected for development of functional fermented milk: L. helveticus strains hv25, hv28, l.a. and L. delbrueckii ssp. bulgaricus strains 4/135 and 4/149 (7) .
Fermentations were carried out in pasteurized (15 min 92 o c) 9% reconstituted skim milk powder for up to 24 hours at 37 o c or 42 o c. For batch fermentations milk was inoculated with 1% or 3% active cultures and incubated at 37 o c for 16 h or 24 h. the fermented milk obtained by the batch method or the respective cell-free supernatant, prepared by centrifugation, were freeze-dried on a laboratory freeze-drier. For ph-controlled fermentations 25 ml overnight cultures were used to inoculate 2,5 l milk medium and incubation at 37 o C at pH = 5,7 in a laboratory fermentor system under nitrogen and neutralization with 10n naoh. Fifty milliliters samples were withdrawn at regular intervals for up to 10 hours and on the 24-th hour. Viable cell counts were measured by plating 10-fold dilutions on MRS-agar and incubation at 37 o c under anaerobic conditions. Yoghurt-like products were obtained by inoculating milk with 2% of coculture of the
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selected lactobacilli with Streptococcus thermophilus strain t8 at 42 o C until pH reached 4.7. To increase the ACEIA, yoghurtlike products were also prepared after the addition of up to 1% of freeze-dried cell-free supernatant obtained earlier in 24 h monoculture batch fermentations (see above).
Quantification of ACE inhibitory activity (ACEIA)
Samples were processed according to nakamura et al. (5) . the AceiA was determined according to cushman and cheung (1) as modified by Nakamura et al. (5) . One unit (1U) of ACEIA was defined as the activity which results in 50% inhibition of the enzyme under the specified assay conditions.
results and Discussion
Accumulation of ACEIA in fermented milk during batch fermentations in batch fermentations the difference in AceiA of milks inoculated with 1 or 3% of culture were not substantially different ( Table 1) . Although acidity was always higher at 42 o c, growth at this temperature did not result in higher ACEIA compared to incubation at 37 o c. invariably the highest AceiA was measured in 24-h samples. therefore for batch preparations it was decided that 24 hours at 37 o c of fermentation with 1% inoculum would produce fermented milk with the highest AceiA. Under these conditions all L. helveticus strains produced milk with ph bellow 4.00 (table 1) while the two L. bulgaricus strains and especially strain 4/149 acidified milk to ph above 4.00, which is technologically more acceptable value. cell counts at 24h were in the range of 3.2 x 10 8 -3.4
x 10 9 cfu/ml. consequently, for further product development studies we selected strains at the two extremes -L. helveticus strain hv28, with the highest AceiA, but very low ph and L. bulgaricus strain 4/149 with comparable AceiA and higher ph value.
accumulation of aceIa in ph-controlled experiments
incubation under ph-controlled conditions is expected to prolong the exponential phase of development of the culture and to increase the concentration of final metabolites in the spent medium. Therefore we attempted to increase the final AceiA in milk by ph-controlled experiments. Peak viable cell count and AceiA values clearly separated the three L. helveticus strains from the two L. bulgaricus cultures. cell counts of L. bulgaricus 4/149 and 4/135 increased to 1.5-3.0 x 10 8 cfu/ml for 6-10 hours of incubation coinciding with the highest AceiA, which decreased after further cultivation ( Table 2) . on the contrary, L. helveticus strains hv28 and l.a. had maximal AceiA after 24h of incubation, although the two strains differed in their growth dynamics. Maximal viable cell counts were 1.0 x 10 9 cfu/ml (24h) and 2.0 x 10 8 cfu/ml (6h) for strains hv28 and l.a, respectively. the AceiA accumulation in milk medium under pH-controlled conditions for all the five strains however remained comparable to the values determined for the batch-fermented samples. therefore it was decided that pH-controlled production strategy will be justified only after further optimization of all fermentation parameters and experimental work continued with batch-fermentation trials. comparison of the aceIa of prototype fermented milk products Batch-fermented milk (24h, 37 o c) with L. helveticus strain hv28 or L. bulgaricus strain 4/149, as well as the cell-free supernatants, separated by centrifugation, were evaluated as potential prototype functional products in fresh or freeze-dried form. the highest AceiA was obtained in the reconstituted (10:1) freeze-dried supernatant as its low-solids content resulted in concentration of AceiA by freeze-drying ( Table 3) . L. helveticus strain hv28 or L. bulgaricus strain 4/149 in combination with S. thermophilus strain were also used to prepare yoghurt-like product to evaluate overall AceiA of the final product. The short incubation period for yoghurt reduced the final ACEIA (Table 3 ). Up to two-fold increase in ACEIA could be achieved if 1% freeze dried supernatant (see above) was added in the first steps of yoghurt production (before inoculation). Although AceiA of yoghurt-like products remained lower compared to single culture fermented milk, they had more acceptable sensory qualities.
conclusions Different prototype fermented milk products with AceiA can be produced using carefully selected dairy lactobacilli. Prolonged fermentation (24h, 37 o c) is required to accumulate substantial AceiA in milk, however the obtained product requires further application of additives to achieve acceptable taste. Another option is the design of yoghurt-like products with lower AceiA, but more suitable for direct consumption. The application of lactobacilli with different acidification rate such as L. helveticus strain hv28 or L. bulgaricus strain 4/149 can provide further options for the development of fermented milk products with AceiA.
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